Powder: -20°C for 3 years | In solvent: -80°C for 1 year
5-HT3 antagonist 5 是喹喔啉 -2- 甲酰胺化合物,是一种5-HT3受体拮抗剂。5-HT3 antagonist 5 对5-HT3激动剂和2-甲基-5-HT 也具有拮抗作用,并在小鼠中表现出抗抑郁作用。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 445 | 现货 | ||
5 mg | ¥ 1,080 | 现货 | ||
10 mg | ¥ 1,660 | 现货 | ||
25 mg | ¥ 3,320 | 现货 | ||
50 mg | ¥ 4,990 | 现货 | ||
100 mg | ¥ 6,880 | 现货 | ||
200 mg | ¥ 9,290 | 现货 | ||
500 mg | ¥ 13,800 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 1,180 | 现货 |
产品描述 | 5-HT3 antagonist 5 is a quinoxalin-2-carboxamide compound which is a 5-HT 3 receptor antagonist. 5-HT3 antagonist 5 exerts antagonism on 5-HT 3 agonist and 2-methyl-5-HT, and exhibits anti-depressant effect in mice [1]. |
体外活性 | 5-HT3 antagonist 5 (compound 4c) shows 5-HT 3 receptor antagonisms in longitudinal muscle myenteric plexus preparation from guinea pig ileum against 5-HT 3 agonist, 2-methyl-5-HT, with pA 2 value of 5 [1]. |
体内活性 | 5-HT3 antagonist 5 (compound 4c) (1 mg/kg; i.p.; single dose) reduces the duration of immobility and shows anti-depressant effect in FST mice [1]. Animal Model: Swiss albino mice (23 ± 2 g) [1] Dosage: 1 mg/kg Administration: Intraperitoneal injection; single dose; locomotor scores tested 10 min after administration Result: Reduced the duration of immobility as compared to the vehicle-treated (control) group. Showed no effect on the locomotion of mice as observed in spontaneous locomotor activity. |
分子量 | 279.29 |
分子式 | C16H13N3O2 |
CAS No. | 901599-43-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
5-HT3 antagonist 5 901599-43-7 WAY327157 WAY 327157 Inhibitor inhibitor inhibit